EDSAEdesa Biotech, Inc.

Nasdaq edesabiotech.com


$ 4.62 $ 0.10 (2.12 %)    

Friday, 10-May-2024 15:02:25 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 4.61
$ 4.62
$ 4.46 x 100
$ 4.78 x 100
$ 4.62 - $ 4.62
$ 2.46 - $ 8.33
7,968
na
14.83M
$ 1.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-09-2024 12-31-2023 10-Q
3 12-15-2023 09-30-2023 10-K
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-Q
7 12-16-2022 09-30-2022 10-K
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 12-28-2021 09-30-2021 10-K
12 08-13-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 12-07-2020 09-30-2020 10-K
16 08-12-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 02-05-2019 12-31-2018 10-Q
22 11-30-2018 09-30-2018 10-K
23 08-08-2018 06-30-2018 10-Q
24 05-07-2018 03-31-2018 10-Q
25 02-07-2018 12-31-2017 10-Q
26 12-01-2017 09-30-2017 10-K
27 08-09-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-06-2017 12-31-2016 10-Q
30 12-14-2016 09-30-2016 10-K
31 08-09-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 02-08-2016 12-31-2015 10-Q
34 12-14-2015 09-30-2015 10-K
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 02-09-2015 12-31-2014 10-Q
38 11-14-2014 08-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 edesa-biotech-q2-eps-058-beats-069-estimate

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.69)...

 hc-wainwright--co-reiterates-buy-on-edesa-biotech-maintains-21-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price ...

 why-reshape-lifesciences-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA P...

 hc-wainwright--co-maintains-buy-on-edesa-biotech-lowers-price-target-to-21

HC Wainwright & Co. analyst Vernon Bernardino maintains Edesa Biotech (NASDAQ:EDSA) with a Buy and lowers the price targ...

 why-urban-outfitters-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter fina...

 hc-wainwright--co-reiterates-buy-on-edesa-biotech-maintains-10-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $10 price ...

 edesa-biotech-reports-final-phase-2b-results-for-dermatitis-study

1.0% Formulation Reached Primary Endpoint with Statistical SignificanceFull Analysis Identified Additional Efficacy Signals

 regulators-approve-updated-phase-3-trial-design-for-edesa-biotechs-ards-drug

Health Canada has approved the company's proposal to harmonize clinical trial designs in the U.S. and Canada for an ongoing...

 why-belden-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing o...

 why-comtech-telecommunications-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.

 why-is-infectious-disease-player-edesa-biotech-stock-soaring-today

Edesa Biotech Inc (NASDAQ: EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Pha...

 why-inmode-shares-are-trading-lower-by-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers

 edesa-biotech-secures-10m-credit-facility-with-company-founder

Revolving Line of Credit to Support Completion of Government-Funded ARDS StudyTORONTO, ON / ACCESSWIRE / October 12, 2023 / Ede...

Core News & Articles

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseas...

 stocks-that-hit-52-week-lows-on-tuesday

  Tuesday saw 132 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION